Each year, 6.3 million pregnant women and newborns die due to complications from pregnancy and childbirth. A staggering 99 percent of maternal deaths occur in developing countries and many could have been prevented with basic interventions had their conditions been diagnosed in a timely manner. The limiting factor in these resource-constrained settings is the inability to screen for these common conditions. Currently available tests for these conditions are too expensive for widespread use in developing countries. The Antenatal Screening Kit consists of extremely inexpensive urine and blood tests for use by semi-trained healthcare workers in developing countries The tests use commercially available reagents delivered through an innovative pen platform that brings the cost of a single test down from 50 cents to 1/3 of a cent.
Sponsor
Clinical Advisor
Graduate Student Team Members
Additional Information
Related News Items